Skip to main content

Table 2 Patient Reported Site-Specific Fat Changes and Body Image Scale Scores

From: Body image in women with HIV: a cross-sectional evaluation

Body Site Fat Change (n) SIBID-S BIQLI
Face Fat Hypertrophy (12) 2.7 (2.3, 2.9)** -0.8 (-1.3, 0.5)*
  Fat Atrophy (12) 2.6 (2.0, 3.1)** -1.0 (-1.3, -0.2)
  No Change (38) 1.7 (0.6, 2.2) 0 (-0.8, 0.4)
Neck Fat Hypertrophy (15) 2.3 (2.1, 2.8)* -1.0 (-1.3, 0)
  Fat Atrophy (1) 3.1** 1.7
  No Change (46) 1.9 (0.8, 2.5) -0.2 (-0.9, 0.4)
Arm Fat Hypertrophy (6) 2.3 (1.9, 3.0) -0.7 (-1.2, 0.8)
  Fat Atrophy (17) 2.5 (2.1, 3.0)** -0.8 (-1.3, 0.2)*
  No Change (39) 1.8 (0.5, 2.4) -0.1 (-0.8, 0.6)
Breast Fat Hypertrophy (18) 2.7 (2.0, 3.0)** -1.0 (-1.3, -0.2)**
  Fat Atrophy (6) 2.4 (1.9, 3.0) 0.9 (-1.0, 2.0)
  No Change (38) 1.8 (0.5, 2.3) -0.1 (-0.8, 0.4)
Abdomen Fat Hypertrophy (39) 2.3 (1.7, 2.8)** -0.7 (-1.2, 0)**
  No Change (23) 1.3 (0.5, 2.3) 0.2 (-0.4, 0.8)
Leg Fat Hypertrophy (8) 2.3 (2.1, 3.2)* -0.8 (-1.1, -0.5)*
  Fat Atrophy (24) 2.3 (1.6, 2.8)* -0.5 (-1.2, 1.0)
  No Change (30) 1.8 (0.5, 2.4) -0.05 (-0.9, 0.5)
Buttock Fat Hypertrophy (8) 2.5 (1.0, 2.9) -0.8 (-1.3, 1.9)
  Fat Atrophy (17) 2.3 (1.9, 2.7) -0.8 (-1.2, 0.2)
  No Change (37) 1.9 (0.7, 2.4) -0.1 (-0.8, 0.4)
  1. Note: Body Image Scale scores reported as Median (IQR).
  2. **Denotes significant difference between group medians (p < 0.025) as determined by Wilcoxon rank sum test comparing fat change group to "no change" control.
  3. * p ≤ 0.05.